2006
DOI: 10.1016/j.athoracsur.2006.06.068
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic Factors and Surgical Indications of Pulmonary Epithelioid Hemangioendothelioma: A Review of the Literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
160
1
16

Year Published

2009
2009
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 167 publications
(180 citation statements)
references
References 28 publications
2
160
1
16
Order By: Relevance
“…Several studies have shown that a partial remission could be achieved with carboplatin, paclitaxel, and bevacizumab, a monoclonal antibody that blocks human vascular endothelial growth factor-A [11]. A partial response of the pulmonary lesions was obtained with interferon α-2a, probably due to its antiangiogenic activity [12]. Follow-up chest CT scan after chemotherapy showed no significant change in the tumor size and number.…”
Section: Discussionmentioning
confidence: 97%
See 2 more Smart Citations
“…Several studies have shown that a partial remission could be achieved with carboplatin, paclitaxel, and bevacizumab, a monoclonal antibody that blocks human vascular endothelial growth factor-A [11]. A partial response of the pulmonary lesions was obtained with interferon α-2a, probably due to its antiangiogenic activity [12]. Follow-up chest CT scan after chemotherapy showed no significant change in the tumor size and number.…”
Section: Discussionmentioning
confidence: 97%
“…Several studies reported that lack of these symptoms was associated with a lower risk for cancer progression [5,12].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…O curso clinico e o prognóstico são imprevisíveis 4,7,8 . São factores de mau prognóstico sintomatologia respiratória na altura do diagnóstico 2,4 , presença de doença multicêntrica, metastização hepática ou ganglionar 2,7 , anemia, hemorragia alveolar e derrame pleural hemático 8 . A sobrevida dos casos descritos na literatura varia entre 2 e 24 anos 4 .…”
Section: Discussionunclassified
“…O hemangioendotelioma epitelial (HE) é uma neoplasia rara com origem no endotélio vascular [2][3][4]7,8 . A apresentação pulmonar foi descrita pela primeira vez em 1975 por Dail e Liebow, que consideraram tratar-se de uma forma intravascular de carcinoma bronquioloalveolar [1][2][3][4][5]7 .…”
Section: Introductionunclassified